Literature DB >> 21464024

[Extraintestinal manifestations of inflammatory bowel diseases and their management].

Mária Garamszegi1.   

Abstract

Extraintestinal manifestations of ulcerative colitis and Crohn's disease are symptoms of varied organ injuries due to systemic inflammatory process. Bowel disease seems to be primary but upon genetic disposition disturbed immune regulation may result in inflammation of other organs that may appear simultaneously, precede bowel disease or follow it in the quiescent phase. As far as possible extraintestinal manifestations have to be distinguished from the complications of the intestinal inflammation and also from side effects of drugs for its treatment. Involvement of bones and joints, skin, eyes, liver and biliary tract is more common but disease of blood coagulation system, lung, kidneys and nervous system may also appear. Treatment of extraintestinal manifestations is influenced by their association with the activity of the bowel disease. Beyond some specific interventions, to achieve improvement of manifestations independent from activity long lasting anti-inflammatory therapy or immunomodulation is almost always needed. Clinical evidence of different levels from reports support the favorable effect of biologic therapy in different extraintestinal manifestations of inflammatory bowel diseases as well. Care and follow-up of patients is a multidisciplinary task.

Entities:  

Mesh:

Year:  2011        PMID: 21464024     DOI: 10.1556/OH.2011.29075

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  1 in total

1.  Midkine level may be used as a noninvasive biomarker in Crohn’s disease

Authors:  Murat Kekilli; Alpaslan Tanoğlu; Fatih Karaahmet; Zeynal Doğan; Murat Can; Abdurrahim Sayilir; Başak Çakal; Tolga Düzenli; Yavuz Beyazit
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.